News

The 120-patient trial demonstrated that patients taking Epidiolex achieved a median reduction in monthly convulsive seizures of 39%, compared with a 13% reduction for those on a placebo,

The collaboration will further explore the scientific and clinical role of citrullinated proteins in the treatment of cancer. Scancell’s Moditope platform technology overcomes the immune suppression induced by

The Company anticipates the following events to occur over the coming months and will provide updates on its EU orphan designation progress as key milestones occur. In the

Sarilumab is being developed by Sanofi and Regeneron Pharmaceuticals, while adalimumab is marketed by AbbVie as Humira. Sarilumab is a human monoclonal antibody directed against the interleukin-6 (IL-6)

The agency’s Center for Veterinary Medicine (FDA-CVM) released in the Federal Register a preliminary finding of no significant impact (FONSI) on OX513A for an investigational trial in the

The drug’s use has been expanded to treat patients with advanced, or metastatic, NSCLC whose tumors have an ROS-1 gene alteration, which is believed to lead to abnormal

The FDA requested additional CMC information for the Multi-Dose Preservative-Free (MDPF) bottle, a first of its kind container with patented uni-directional valve and air filter technology. Allergan is

The shared goal is the identification and validation of novel druggable sites in disease pathways, and the development of a pipeline of novel therapeutic targets in the oncology

The Series B financing was provided by Hiroshi Mikitani through his personal investment companies. Hiroshi Mikitani is the CEO of Rakuten, Inc., one of the world’s leading internet